Literature DB >> 10570911

Mutational analysis of TSC1 and TSC2 genes in Japanese patients with tuberous sclerosis complex.

H Zhang1, E Nanba, T Yamamoto, H Ninomiya, K Ohno, M Mizuguchi, K Takeshita.   

Abstract

We have surveyed the mutations of TSC1 and TSC2 from 38 (25 sporadic, 11 familial, and 2 unknown) Japanese patients with tuberous sclerosis complex. In 23 of 38 subjects, we detected 18 new mutations in addition to 4 mutations that had been previously reported. We also found 3 new polymorphisms. The mutations were not clustered on a particular exon in either of the genes. Seven TSC1 mutations found in 3 familial and 4 sporadic cases were on the exons (3 missense, 2 nonsense point mutations, a 1-base insertion, and a 2-bp deletion). Fifteen TSC2 mutations were found in 5 familial cases, 10 sporadic cases, and 1 unknown case. The 12 mutations were on the exons (8 missense, 1 nonsense point mutations, a 1-bp insertion, a 5-bp deletion, and a 4-bp replacement) and 3 point mutations were on the exon-intron junctions. Although the patients with TSC2 mutations tend to exhibit relatively severe mental retardation in comparison to those with TSC1 mutations, a genotype-phenotype correlation could not yet be established. The widespread distribution of TSC1/TSC2 mutations hinders the development of a simple diagnostic test, and the identification of individual mutations does not provide the prediction of prognosis.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10570911     DOI: 10.1007/s100380050185

Source DB:  PubMed          Journal:  J Hum Genet        ISSN: 1434-5161            Impact factor:   3.172


  7 in total

1.  Expansion of genetic testing in the division of functional genomics, research center for bioscience and technology, tottori university from 2000 to 2013.

Authors:  Kaori Adachi
Journal:  Yonago Acta Med       Date:  2014-04-28       Impact factor: 1.641

Review 2.  The molecular genetics of autism.

Authors:  T H Wassink; J Piven
Journal:  Curr Psychiatry Rep       Date:  2000-04       Impact factor: 5.285

3.  Chemical chaperone therapy for brain pathology in G(M1)-gangliosidosis.

Authors:  Junichiro Matsuda; Osamu Suzuki; Akihiro Oshima; Yoshie Yamamoto; Akira Noguchi; Kazuhiro Takimoto; Masayuki Itoh; Yuji Matsuzaki; Yosuke Yasuda; Seiichiro Ogawa; Yuko Sakata; Eiji Nanba; Katsumi Higaki; Yoshimi Ogawa; Lika Tominaga; Kousaku Ohno; Hiroyuki Iwasaki; Hiroshi Watanabe; Roscoe O Brady; Yoshiyuki Suzuki
Journal:  Proc Natl Acad Sci U S A       Date:  2003-12-15       Impact factor: 11.205

4.  Molecular and clinical analyses of 84 patients with tuberous sclerosis complex.

Authors:  Chia-Cheng Hung; Yi-Ning Su; Shu-Chin Chien; Horng-Huei Liou; Chih-Chuan Chen; Pau-Chung Chen; Chia-Jung Hsieh; Chih-Ping Chen; Wang-Tso Lee; Win-Li Lin; Chien-Nan Lee
Journal:  BMC Med Genet       Date:  2006-09-18       Impact factor: 2.103

5.  Response to everolimus is seen in TSC-associated SEGAs and angiomyolipomas independent of mutation type and site in TSC1 and TSC2.

Authors:  David J Kwiatkowski; Michael R Palmer; Sergiusz Jozwiak; John Bissler; David Franz; Scott Segal; David Chen; Julian R Sampson
Journal:  Eur J Hum Genet       Date:  2015-03-18       Impact factor: 4.246

6.  Bladder tumour-derived somatic TSC1 missense mutations cause loss of function via distinct mechanisms.

Authors:  Louis S Pymar; Fiona M Platt; Jon M Askham; Ewan E Morrison; Margaret A Knowles
Journal:  Hum Mol Genet       Date:  2008-04-07       Impact factor: 6.150

7.  Novel and de novo mutations in pediatric refractory epilepsy.

Authors:  Jing Liu; Lili Tong; Shuangshuang Song; Yue Niu; Jun Li; Xiu Wu; Jie Zhang; Clement C Zai; Fang Luo; Jian Wu; Haiyin Li; Albert H C Wong; Ruopeng Sun; Fang Liu; Baomin Li
Journal:  Mol Brain       Date:  2018-09-05       Impact factor: 4.041

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.